NEW YORK--(BUSINESS WIRE)--Tyme Technologies Inc. (OTC QB: TYMI), a research and development company focused on developing drug candidates for the treatment of cancer, has announced the appointment of Daniel Petrylak, MD of Yale Oncology as a member of its Medical Advisory Board. Based out of New York, Dr. Petrylak will oversee the Company’s clinical studies. Dr. Petrylak is a pioneer in the research and development of new drugs and treatments to fight prostate, bladder, kidney and testicular cancers.
Help employers find you! Check out all the jobs and post your resume.
